Neuro Notes

• The Impact of Social Determinants of Health on Epilepsy Treatment   Andrew N. Wilner, MD, and Joseph I. Sirven, MD, discuss the impact of social determinants of health on epilepsy.
  Medscape Neurology, January 30, 2023
• Neurologic Symptoms in People With Long COVID   Dr Andrew Wilner and Dr Igor Koralnik discuss the range of neurologic symptoms that can persist after acute COVID-19.
  Medscape Neurology, December 22, 2022
• Starting Lamotrigine: Who Needs an EKG?   Drs Wilner and French discuss the latest FDA label changes on lamotrigine and what they mean in practice.
  Medscape Neurology, November 22, 2022
• Long-Acting, Subcutaneous Levodopa In Parkinson's Disease: Is It Safe?   Priming the pump in Parkinson's disease -- a new levodopa solution. Join Dr Andrew Wilner as he discusses the safety of this new method of administration with Dr Jason Aldred.
  Medscape Neurology, September 07, 2022
• CGRP Receptor Antagonists for Migraine Prevention: What's New   Drs Andrew Wilner and David Dodick discuss CGRP receptor antagonists and a recent abstract presented at the 2022 American Academy of Neurology meeting.
  Medscape Neurology, August 19, 2022
• Antiseizure Drugs Associated With Movement Disorders   New findings are linking certain antiseizure medications to movement disorders in patients with epilepsy.
  Medscape Neurology, June 13, 2022
• Skin Testing May Help Detect Movement Disorders   Drs Andrew Wilner and Christopher Gibbons discuss recent data on alpha-synuclein in the context of synucleinopathies presented at the 2022 American Academy of Neurology meeting.
  Medscape Neurology, May 18, 2022
• Smartphone Diagnosis in Infant Seizures: Highly Effective?   Drs Andrew Wilner and Chethan Rao discuss the potential use for smartphone video as an important adjunct in the diagnosis and treatment of infantile spasms.
  Medscape Neurology, April 27, 2022
• What's Wrong With EEG Interpretation   Dr Andrew Wilner speaks with epilepsy expert Dr Selim Benbadis about how EEG overinterpretation undercuts epilepsy management.
  Medscape Neurology, March 02, 2022
• Antiseizure Meds and Cardiovascular Risk   Dr Andrew Wilner speaks with researcher Dr Colin Josephson about how big data is revealing the ways that certain epilepsy treatments elevate risks.
  Medscape Neurology, February 28, 2022
• A Rare Case of Status Epilepticus in a Patient Prescribed CBD   Dr Andrew Wilner speaks with an investigator who encountered a surprising complication after transitioning a patient with intractable focal epilepsy to CBD adjunctive therapy.
  Medscape Neurology, February 02, 2022
• A Game-Changing Trial Offers New Hope for ALS   Dr Andrew Wilner speaks with Dr Sabrina Paganoni about the CENTAUR trial, whose results made a big splash at the recent AAN annual meeting.
  Medscape Neurology, August 13, 2021
• Filming Seizures -- A HIPAA Violation? Capturing a patient's seizure on video can be invaluable in making an accurate diagnosis. But patient privacy laws often get in the way.
  Medscape Neurology, July 26, 2021
• Some 'Novel' Surprises in Epilepsy Data   Epilepsy expert Dr Joseph Sirven shares his highlights from this year's AAN annual meeting with Dr Andrew Wilner.
  Medscape Neurology, June 11, 2021
• How HIPAA Can Harm Patients As Dr Andrew Wilner has experienced first-hand, HIPAA may not always be in the patient's best interest.
  Medscape Neurology, April 23, 2021
• New Guidance on Identifying Brain Death   Dr Andrew Wilner interviews Dr Gene Sung, lead author of the new guidelines from the World Brain Death Project.
  Medscape Neurology, January 06, 2021
• Could RAS Dysfunction Explain COVID's Effects? Dr Andrew Wilner speaks with the researcher proposing that the renin-angiotensin system is the reason for COVID-19's complex symptoms.
  Medscape Neurology, December 18, 2020
• How a Medical School Dean Got Ahead of COVID-19   Dr Andrew Wilner talks with Dr Scott Strome, executive dean and vice chancellor for Clinical Affairs at University of Tennessee Health Science Center.
  Medscape Neurology, November 25, 2020
• Why Are Cases of SUDEP Declining?   Dr Andrew Wilner speaks with Dr Daniel Friedman about how expanded coverage and increased awareness may be reducing sudden unexplained death in epilepsy.
  Medscape Neurology, September 23, 2020
• Talking Through Pandemic Anxiety With a Pioneer of Mind-Body Medicine   Dr Andrew Wilner speaks with Dr James Gordon about drawing on his decades of experience to stay mentally and physically healthy in a year of unprecedented challenges.
  Medscape Neurology, July 15, 2020